drugset / Trial / NCT05458856
Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate
NaSingle-groupOpen-labelTreatment
Summary
The aim of the study is to determine if triptorelin formulated for use every 6 months (given twice during the study) is effective and safe for when given by injection under the skin for the treatment of adult males with cancer in the prostate.
Timeline
- Start
- 2022-08-30
- Primary completion
- 2024-07-08
- Completion
- 2024-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triptorelin | Other / unclassified | 22.5 mg | Subcutaneous |